Figure 7From: Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceOverall PFS. 0: RIT as primary therapy; mean 24.8 months, 95% CI 19.0-30.6 months 3. 1: RIT for disease relapse; mean 8.7 months; 95% CI 5.2 - 12.3 months. 2: RIT as re-RT; mean 8.6 months; 95% CI 6.5 - 10.6 months. p = 0.0014 (0 vs 1); p = 0.001 (0 vs 2), p = ns (1 vs 2)Back to article page